Table 3:
Multivariable analysis for recurrence-free survival and overall survival
| Survival | Characteristic | HR | 95% UB | 95% LB | p-value |
|---|---|---|---|---|---|
| OS | Age at diagnosis (in years) | 1.05 | 1.03 | 1.08 | <0.001 |
| FIGO stage (ref: IA) | |||||
| IB | 1.64 | 0.91 | 2.95 | 0.100 | |
| II | 3.04 | 1.51 | 6.13 | 0.002 | |
| LVSI | 1.10 | 0.66 | 1.81 | 0.722 | |
| Rhabdomyosarcoma component | 1.66 | 1.02 | 2.70 | 0.041 | |
| RFS | Age at diagnosis (in years) | 1.03 | 1.01 | 1.05 | 0.011 |
| FIGO stage (ref: IA) | |||||
| IB | 1.95 | 1.11 | 3.41 | 0.019 | |
| II | 2.86 | 1.46 | 5.60 | 0.002 | |
| LVSI | 0.86 | 0..53 | 1.39 | 0.532 | |
| Rhabdomyosarcoma component | 1.50 | 0.94 | 2.40 | 0.090 | |